Liver circadian clock regulates hepatokine secretion
Analysis based on 6 articles · First reported Aug 12, 2026 · Last updated Aug 20, 2026
The study is early-stage basic research with no immediate market impact. It may influence future drug development in metabolic disease, potentially benefiting biotech and pharmaceutical companies focused on chronotherapy and peptide-based treatments.
Researchers at UT Health San Antonio, the academic health center of The University of Texas at San Antonio, published a study in Tata Communications on June 2, 2026, revealing that the liver's internal circadian clock controls the time-dependent secretion of hepatokines—proteins that regulate metabolism. The study, led by Kevin Koronowski and first-authored by Bong Go, analyzed the liver's secreted proteome in mice and identified hundreds of proteins released on daily schedules. A key finding was that endostatin, a liver protein, was most effective at promoting fat breakdown when released according to the liver's natural daily rhythm. This suggests that future metabolic treatments based on such proteins might be more effective if administered at specific times of day. The research was supported by the United States — National Institutes of Health and the American Heart Association. The findings provide a mechanism linking circadian disruption to metabolic disease and could inform chronotherapy approaches, though no clinical treatments are established yet.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard